Fred E Cohen Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Fred E Cohen.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Fred E Cohen. Fred E Cohen is Director in BIOCRYST PHARMACEUTICALS INC ($BCRX) and Director in GENOMIC HEALTH INC ($GHDX) and Director in FIVE PRIME THERAPEUTICS INC ($FPRX) and Director in CareDx, Inc. ($CDNA) and Director in VERACYTE, INC. ($VCYT) and Director in TANDEM DIABETES CARE INC ($TNDM) and Director in Roka BioScience, Inc. ($ROKA) and Director in Progyny, Inc. ($PGNY) and Director in Intellia Therapeutics, Inc. ($NTLA) and Director in UroGen Pharma Ltd. ($URGN).
Latest Insider Trading Transactions of Fred E Cohen
Sentiment: All, BCRX, CDNA, FPRX, GHDX, NTLA, PGNY, ROKA, TNDM, URGN, VCYT
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 02 2016 | BCRX | BIOCRYST PHARMACEU ... | Cohen Fred E | Director | Grant | A | 3.39 | 2,581 | 8,750 | 111,646 | 109.1 K to 111.6 K (+2.37 %) |
| May 25 2016 | BCRX | BIOCRYST PHARMACEU ... | Cohen Fred E | Director | Option Exercise | A | 3.22 | 30,000 | 96,600 | 30,000 | |
| May 23 2016 | FPRX | FIVE PRIME THERAPE ... | Cohen Fred E | Director | Option Exercise | A | 42.25 | 10,000 | 422,500 | 0 | |
| Apr 04 2016 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Grant | A | 25.48 | 392 | 9,988 | 64,520 | 64.1 K to 64.5 K (+0.61 %) |
| Apr 05 2016 | CDNA | CareDx, Inc. | Cohen Fred E | Director | Grant | A | 0.00 | 1,954 | 0 | 8,901 | 6.9 K to 8.9 K (+28.13 %) |
| Mar 01 2016 | BCRX | BIOCRYST PHARMACEU ... | Cohen Fred E | Director | Grant | A | 1.99 | 4,396 | 8,748 | 109,065 | 104.7 K to 109.1 K (+4.20 %) |
| Jan 13 2016 | FPRX | FIVE PRIME THERAPE ... | Cohen Fred E | Director | Option Exercise | M | 12.70 | 12,500 | 158,750 | 0 | |
| Jan 13 2016 | FPRX | FIVE PRIME THERAPE ... | Cohen Fred E | Director | Option Exercise | M | 7.26 | 4,065 | 29,512 | 0 | |
| Jan 13 2016 | FPRX | FIVE PRIME THERAPE ... | Cohen Fred E | Director | Option Exercise | M | 5.54 | 4,065 | 22,520 | 0 | |
| Jan 13 2016 | FPRX | FIVE PRIME THERAPE ... | Cohen Fred E | Director | Option Exercise | M | 8.49 | 4,065 | 34,512 | 0 | |
| Jan 13 2016 | FPRX | FIVE PRIME THERAPE ... | Cohen Fred E | Director | Buy | M | 12.70 | 12,500 | 158,750 | 24,807 | 12.3 K to 24.8 K (+101.57 %) |
| Jan 13 2016 | FPRX | FIVE PRIME THERAPE ... | Cohen Fred E | Director | Buy | M | 7.26 | 4,065 | 29,512 | 12,307 | 8.2 K to 12.3 K (+49.32 %) |
| Jan 13 2016 | FPRX | FIVE PRIME THERAPE ... | Cohen Fred E | Director | Buy | M | 5.54 | 4,065 | 22,520 | 8,242 | 4.2 K to 8.2 K (+97.32 %) |
| Jan 13 2016 | FPRX | FIVE PRIME THERAPE ... | Cohen Fred E | Director | Buy | M | 8.49 | 4,065 | 34,512 | 4,177 | 112 to 4.2 K (+3,629.46 %) |
| Jan 05 2016 | CDNA | CareDx, Inc. | Cohen Fred E | Director | Grant | A | 0.00 | 1,836 | 0 | 6,947 | 5.1 K to 6.9 K (+35.92 %) |
| Jan 05 2016 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Grant | A | 35.20 | 284 | 9,997 | 64,128 | 63.8 K to 64.1 K (+0.44 %) |
| Dec 03 2015 | BCRX | BIOCRYST PHARMACEU ... | Cohen Fred E | Director | Grant | A | 10.61 | 824 | 8,743 | 104,669 | 103.8 K to 104.7 K (+0.79 %) |
| Nov 17 2015 | TNDM | TANDEM DIABETES CA ... | Cohen Fred E | Director | Option Exercise | A | 10.13 | 17,000 | 172,210 | 17,000 | |
| Oct 05 2015 | CDNA | CareDx, Inc. | Cohen Fred E | Director | Grant | A | 0.00 | 1,008 | 0 | 5,111 | 4.1 K to 5.1 K (+24.57 %) |
| Oct 05 2015 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Grant | A | 21.34 | 468 | 9,987 | 63,844 | 63.4 K to 63.8 K (+0.74 %) |
| Sep 02 2015 | BCRX | BIOCRYST PHARMACEU ... | Cohen Fred E | Director | Grant | A | 11.64 | 751 | 8,742 | 103,845 | 103.1 K to 103.8 K (+0.73 %) |
| Jul 06 2015 | CDNA | CareDx, Inc. | Cohen Fred E | Director | Grant | A | 0.00 | 1,227 | 0 | 4,103 | 2.9 K to 4.1 K (+42.66 %) |
| Jul 06 2015 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Grant | A | 27.34 | 365 | 9,979 | 63,376 | 63 K to 63.4 K (+0.58 %) |
| Jun 26 2015 | ROKA | Roka BioScience, I ... | Cohen Fred E | Director | Option Exercise | A | 2.75 | 15,000 | 41,250 | 15,000 | |
| Jun 17 2015 | CDNA | CareDx, Inc. | Cohen Fred E | Director | Option Exercise | A | 6.08 | 5,255 | 31,950 | 5,255 | |
| Jun 16 2015 | FPRX | FIVE PRIME THERAPE ... | Cohen Fred E | Director | Option Exercise | A | 22.15 | 12,500 | 276,875 | 12,500 | |
| Jun 15 2015 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Option Exercise | A | 26.01 | 10,000 | 260,100 | 10,000 | |
| Jun 01 2015 | BCRX | BIOCRYST PHARMACEU ... | Cohen Fred E | Director | Grant | A | 11.21 | 780 | 8,744 | 103,094 | 102.3 K to 103.1 K (+0.76 %) |
| May 22 2015 | BCRX | BIOCRYST PHARMACEU ... | Cohen Fred E | Director | Option Exercise | A | 11.39 | 15,000 | 170,850 | 15,000 | |
| May 21 2015 | VCYT | VERACYTE, INC. | Cohen Fred E | Director | Option Exercise | A | 10.41 | 10,000 | 104,100 | 10,000 | |
| Apr 03 2015 | CDNA | CareDx, Inc. | Cohen Fred E | Director | Grant | A | 0.00 | 1,075 | 0 | 2,876 | 1.8 K to 2.9 K (+59.69 %) |
| Apr 03 2015 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Grant | A | 30.43 | 328 | 9,981 | 63,011 | 62.7 K to 63 K (+0.52 %) |
| Mar 03 2015 | BCRX | BIOCRYST PHARMACEU ... | Cohen Fred E | Director | Grant | A | 10.20 | 857 | 8,741 | 102,314 | 101.5 K to 102.3 K (+0.84 %) |
| Oct 06 2005 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Option Exercise | C | 0.00 | 99,999 | 0 | 0 | |
| Oct 06 2005 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Buy | C | 0.00 | 33,333 | 0 | 43,351 | 10 K to 43.4 K (+332.73 %) |